logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
R

Reid W. Merryman

dana-farber cancer institute
H指数:20
被引数:2,116

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safe Accelerated Venetoclax Escalation: a phase 1b study of obinutuzumab plus venetoclax with daily ramp-up in CLL

安全加速Venetoclax剂量递增：一项obinutuzumab联合Venetoclax每日递增剂量方案在CLL中的1b期研究

Blood Advances
IF7.1
2026-06-250
OA
Jennifer L. Crombie; Inhye E. Ahn; Yue Ren; Svitlana Tyekucheva; Celeste Carey; Mari Kniezewski; Samantha Normilus; Shantal Solomon; Josie Montegaard; Austin I. Kim; Reid W. Merryman; Philippe Armand; David C. Fisher; Jennifer R. Brown; Matthew S. Davids
Outcomes of patients with relapsed or refractory classic Hodgkin lymphoma after frontline brentuximab vedotin

复发或难治性经典霍奇金淋巴瘤患者一线使用 Brentuximab Vedotin 后的结局

Blood Cancer Journal
IF11.6
2026-06-250
OAAI
Shin Yeu Ong; Lu Chen; Jomel Meeko Manzano; Reid Merryman; Harsh Shah; Robert Stuver; Sanjal H. Desai; Ann LaCasce; Ayo Falade; Kelsey Baron; Nivetha Ganesan; Tiffany Chang; Urshila Durani; Tamer Othman; Philippe Armand; Matthew Mei; Alison J. Moskowitz; Alex F. Herrera
Clinical outcomes of CD3xCD20 bispecific antibodies in patients with central nervous system involvement by lymphoma

中枢神经系统淋巴瘤患者中CD3xCD20双特异性抗体的临床疗效

Blood Cancer Journal
IF11.6
2026-05-220
OAAI
Karan L. Chohan; Rina L. Welkie; James Godfrey; Steven Bair; Lorenzo Falchi; Manali Kamdar; Ajay Major; Wendy Dixon; Jennifer Crombie; Reid Merryman; Sonia Godbole; Gilles Salles; Omnia Farahat; Amy Ayers; Ayushi Chauhan; Alex Herrera; Geoffrey Shouse; Sairah Ahmed; Yazeed Sawalha
Outcomes of Hematopoietic Cell Transplantation in Patients with Plasmablastic Lymphoma

造血细胞移植在浆细胞样淋巴瘤患者中的结局

Transplantation and Cellular Therapy
IF4.4
2026-05-210
PRE
Taha Al-Juhaishi; Kwang Woo Ahn; Tiening Chen; Krina K. Patel; Jinalben Patel; Alex F. Herrera; Cameron J. Turtle; J. Douglas Rizzo; Farhad Khimani; Farrukh T. Awan; Fernando Gibran-Nunes; Gulrayz Ahmed; John Baird; Lazaros J. Lekakis; Mazyar Shadman; Mona Shafey; Peter A. Reidell; Reid W. Merryman; Mehdi Hamadani; Sairah Ahmed
Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton’s tyrosine kinase inhibitor therapy

套细胞淋巴瘤在序贯一线 bendamustine-rituximab 和二线 Bruton 酪氨酸激酶抑制剂治疗后的预后

Blood Cancer Journal
IF11.6
2026-04-250
OAAI
Yucai Wang; Melissa C. Larson; Steven R. Hwang; Diego Villa; Laveniya Kugathasan; Anita Kumar; Ashlee Joseph; Taylor R. Brooks; Brian T. Hill; David A. Bond; Kami J. Maddocks; Alexey Danilov; Christine Argao; Jia Ruan; Imran A. Nizamuddin; Brad S. Kahl; Natalie S. Grover; Nazneen B. Khan; Georgios N. Pongas; Izidore S. Lossos; Evguenia Ouchveridze; Aung M. Tun; Firas Baidoun; Muhamad Alhaj Moustafa; Zoey I. Harris; Javier L. Munoz; Philip R. Young; Craig A. Portell; Patrick M. Reagan; Christine E. Ryan; Reid W. Merryman; Arash Velayati; I. Brian Greenwell; Drew G. Gerber; Preetesh Jain; Michael L. Wang; Sabarish R. Ayyappan; Eric Mou; Lauren G. Banaszak; Priyanka A. Pophali; Anthony C. Stack; Marcus R. Messmer; Mayur S. Narkhede; Amitkumar Mehta; Tamara K. Moyo; Nilanjan Ghosh; Rahul S. Bhansali; Stefan K. Barta; Manali K. Kamdar; Jacob Anna; Alexander V. Stanisic; Reem Karmali; Matthew J. Maurer; James R. Cerhan; Jonathon B. Cohen; Peter Martin
Real-World Evidence for Pembrolizumab Gemcitabine Vinorelbine and Liposomal Doxorubicin in Classical Hodgkin Lymphoma

真实世界证据：帕博利珠单抗、吉西他滨、长春瑞滨和脂质体多柔比星在经典霍奇金淋巴瘤中的应用

Blood Advances
IF7.1
2026-03-230
OAAI
Grace Baek; Gaurav Varma; Samuel Yamshon; Herman van Besien; Nancy L. Bartlett; Marcus Watkins; Harsh R. Shah; Kelsey Baron; Reid W. Merryman; Ayo S. Falade; Jakub Svoboda; Sara Prischak; Christopher D’Angelo; Joe D. Lukowski; Ranjana H. Advani; Austin H Yeung; Maya Rosenberg; Jenna Voutsinas; Mengyang Di; Ryan Lynch
ASTCT Clinical Practice Recommendations for Transplantation in Classical Hodgkin Lymphoma

ASTCT关于经典霍奇金淋巴瘤移植治疗的临床实践建议

Transplantation and Cellular Therapy
IF4.4
2025-12-300
OAAI
Sairah Ahmed; Ambuj Kumar; Paul Carpenter; Alex Herrera; Kara Kelly; Chelsea Pinnix; Sarah Rutherford; Natalie Grover; Andrew Evens; Ryan Lynch; Vaishalee Kenkre; Reid Merryman; Craig Sauter; Taiga Nishihori; Alison Moskowitz; Farrukh Awan; Jakub Svoboda; Jane Winter; Pamela Allen; Ralph Ermoian
PD-1-based combinations before autologous transplant are associated with improved outcomes in classical Hodgkin Lymphoma

基于PD-1的组合疗法在自体移植前与经典霍奇金淋巴瘤的改善预后相关。

Blood
IF23.1
2025-12-190
PRE
Sanjal H. Desai; Alison J. Moskowitz; Reid W. Merryman; Harsh Shah; Levi D. Pederson; Susan M. Geyer; Nivetha Ganesan; Tiffany Chang; Tamer Othman; Ayo S Falade; Gunjan L. Shah; Urshila Durani; Nuttavut Sumransub; Lay She Ng; Kelsey Baron; Shin Yeu Ong; Kevin Yoon; Stephen M Ansell; Philippe Armand; Siddharth Iyengar
Benefit of Rituximab Maintenance After First-line Bendamustine-Rituximab in Patients with Mantle Cell Lymphoma

利妥昔单抗维持治疗在一线苯达莫司汀联合利妥昔单抗治疗后滤泡性淋巴瘤患者中的获益

Blood Advances
IF7.1
2025-12-150
OAAI
Yucai Wang; Melissa C. Larson; Steven R. Hwang; Diego Villa; Laveniya Kugathasan; Anita Kumar; Ashlee Joseph; Taylor R. Brooks; Brian T. Hill; David A. Bond; Kami J. Maddocks; Imran A. Nizamuddin; Brad S. Kahl; Alexey Danilov; Christine Argao; Jia Ruan; Christine E. Ryan; Reid W. Merryman; Natalie S. Grover; Nazneen B. Khan
Consensus Recommendations from the 2024 International Follicular Lymphoma Scientific Workshop

2024年国际滤泡性淋巴瘤科学研讨会共识建议

Blood Advances
IF7.1
2025-12-050
OAAI
Reid Merryman; Sarah C. Rutherford; Stephen Ansell; Philippe Armand; John P. Leonard; Loretta Nastoupil; Sonali M. Smith; John Timmerman; Andrew D. Zelenetz; Meghan Gutierrez; Wendy Béguelin; Carla Casulo; James Cerhan; Michael Green; Brad Kahl; Robert Kridel; Brian Link; Matthew J. Maurer; Bertrand Nadel; Andrea J. Radtke
Fixed-Duration Epcoritamab Plus R2 Drives Favorable Outcomes in Relapsed or Refractory Follicular Lymphoma

固定疗程的Epcoritamab联合R2方案可改善复发或难治性滤泡性淋巴瘤患者的预后。

Blood
IF23.1
2025-09-100
OAAI
Lorenzo Falchi; Anna Sureda; Sirpa Leppä; Joost S.P. Vermaat; Marcel Nijland; Jacob Haaber Christensen; Sven de Vos; Harald Holte; Reid W. Merryman; Pieternella J. Lugtenburg; Pau Abrisqueta; Kim M. Linton; Gauri Sunkersett; Daniela Hoehn; Ali Rana; Aqeel Abbas; Jennifer Marek; Yi Hao; Andrew J. Steele; Christopher Morehouse; Martin Hutchings; David Belada
Treatment and outcomes of progression of disease post-CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis

CAR T细胞疗法后套细胞淋巴瘤疾病进展的治疗与结局：一项多中心分析

Blood Advances
IF7.1
2025-08-070
OAAI
Zachary D. Epstein-Peterson; Anath C. Lionel; Ashlee Joseph; Esther Drill; Suheil Albert Atallah-Yunes; Taylor R. Brooks; Elise A. Chong; Emeline R. Chong; Jamie Dela Cruz; Matthew J. Frank; Andrew Ip; Madiha Iqbal; Caron A. Jacobson; Manali K. Kamdar; Reem Karmali; Ofrat Beyar-Katz; Kami J. Maddocks; Matthew J. Matasar; Daniel McLoughlin; Reid W. Merryman
Measurable Residual Disease Detection after CAR-T May Predict Response in Patients with Large B-cell Lymphoma

CAR-T治疗后微小残留病检测可预测大B细胞淋巴瘤患者的治疗反应

Blood Advances
IF7.1
2025-07-280
OAAI
Nira Krasnow; Katie Maurer; Catherine Song; Justin Rhoades; Kan Xiong; Andjela Crnjac; Timothy Blewett; Lily Gao; Heather Jacene; Reid Merryman; Satyen H. Gohil; Caitlyn Duffy; Liliana I. Guerrero; Jamie Dela Cruz; Mikaela McDonough; Jacquelyn O. Wolff; Robert Redd; Mike Mattie; Brodie Miles; G. Mike Makrigiorgos; Donna S. Neuberg; Scott J. Rodig; Philippe Armand; Caron Jacobson; Viktor A. Adalsteinsson; Catherine J. Wu
Longitudinal Patient-Reported Outcomes in Older Adults With Aggressive Lymphomas Receiving Chemoimmunotherapy

老年侵袭性淋巴瘤患者接受化疗免疫疗法后的纵向患者报告结局

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
2025-02-190
PRE
Johnson, P. Connor; Abramson, Jeremy S.; Lacasce, Ann S.; Armand, Philippe; Barnes, Jeffrey; Merryman, Reid W.; Soumerai, Jacob; Hochberg, Ephraim; Takvorian, Ronald W.; Jacobson, Caron A.; Crombie, Jennifer L.; Fisher, David C.; Schwartz, Joel; Friedman, Robb S.; Stacey, Julia; Yang, Daniel; Coffey, Bridget; Markowitz, Netana; Odejide, Oreofe O.; El-Jawahri, Areej
Outcomes of CD19 CAR T in Transformed Indolent Lymphoma Compared to De Novo Aggressive Large B-Cell Lymphoma

与新生侵袭性大b细胞淋巴瘤相比，CD19 CAR T在转化的惰性淋巴瘤中的结果

AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2024-12-230
OAAI
Thiruvengadam, Swetha Kambhampati; Merryman, Reid; Wang, Yan; Gaulin, Charles; Bezerra, Evandro; Voorhees, Timothy; Seshadri, Madhav R.; Falade, Ayo; Habib, Alma; Ayers, Amy A.; Bailey, Megumi; Brown, Annette; Bailey, Neil; Patel, Krish; Andreadis, Charalambos B.; Kittai, Adam S.; Jacobson, Caron; Palmer, Joycelynne; Forman, Stephen J.; Nastoupil, Loretta; Budde, Lihua E.
EO2463 Peptide Immunotherapy in Patients with Newly Diagnosed Asymptomatic Follicular Lymphoma Results in Monotherapy Objective Clinical Responses Linked with Anti-Peptide Specific CD8 Memory T Cell Responses: The EONHL1-20/Sidney Study

EO2463肽免疫疗法在 newly diagnosed asymptomatic follicular lymphoma 患者中单药治疗产生客观临床应答，这些应答与抗肽特异性CD8记忆T细胞应答相关：EONHL1-20/Sidney研究

BLOOD
IF23.1
2024-11-050
PRE
Bisneto, Jose C. Villasboas; Smith, Stephen D.; Wallace, Danielle S.; Marolleau, Jean Pierre; Garcia, Carlos Grande; Merryman, Reid W.; Bosch, Francesc; Arcaini, Luca; Pinto, Antonio; Gutierrez, Norma C.; Till, Brian G.; Morel, Pierre; Mora, Rocio Figueroa; Garcia, Cristina; Rattotti, Sara; Aubergeon, Lucie; Chene, Laurent; Fagerberg, Jan; Zinzani, Pier Luigi; Armand, Philippe; Friedberg, Jonathan W.; Ansell, Stephen M.
Long-Term Follow-up of Bendamustine/Rituximab- Rituximab/Cytarabine (BR/RC) Induction Therapy for Previously Untreated Transplant-Eligible Patients with Mantle Cell Lymphoma (MCL)

bendamustine/Rituximab- Rituximab/Cytarabine (BR/RC)诱导治疗对先前未治疗的移植符合条件的套细胞淋巴瘤(MCL)患者的长期随访

BLOOD
IF23.1
2024-11-050
PRE
Ryan, Christine E.; Nizamuddin, Imran A.; Raman, Hari S.; Redd, Robert A.; Watkins, Marcus P.; Lacasce, Ann S.; Fisher, David C.; Kim, Austin I.; Davids, Matthew S.; Jacobson, Caron A.; Odejide, Oreofe O.; Crombie, Jennifer L.; Mehta-Shah, Neha; Cashen, Amanda F.; Ghobadi, Armin; Bartlett, Nancy L.; Jacobsen, Eric D.; Armand, Philippe; Kahl, Brad S.; Merryman, Reid W.
Ipilimumab with and without Nivolumab in Patients with Classic Hodgkin Lymphoma with Progression after PD-1 Blockade

伊匹木单抗联合或不联合纳武利尤单抗治疗PD-1阻断治疗后进展的经典型霍奇金淋巴瘤患者

BLOOD
IF23.1
2024-11-050
PRE
Merryman, Reid W.; Kline, Justin; Redd, Robert A.; Welsh, Emma L.; Pfaff, Kathleen; Lee, Hannah Juhaie; Mcdonough, Mikaela M.; Ahn, Inhye E.; Brown, Jennifer R.; Crombie, Jennifer L.; Davids, Matthew S.; Fisher, David C.; Jacobsen, Eric D.; Jacobson, Caron A.; Kim, Austin I.; Odejide, Oreofe O.; Parry, Erin M.; Ryan, Christine E.; Shipp, Margaret A.; Armand, Philippe; Rodig, Scott J.; Abramson, Jeremy S.; Lacasce, Ann S.
Treatment Patterns and Outcomes Following Progression of Disease Post-CAR-T Therapy in Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter Analysis

CAR-T疗法后疾病进展的复发或难治性套细胞淋巴瘤患者的治疗方案与结局：一项多中心分析

BLOOD
IF23.1
2024-11-050
PRE
Epstein-Peterson, Zachary D.; Lionel, Anath C.; Joseph, Ashlee; Drill, Esther; Atallah-Yunes, Suheil Albert; Brooks, Taylor R.; Chong, Elise A.; Chong, Emeline R.; Dela Cruz, Jamie; Frank, Matthew J.; Ip, Andrew; Iqbal, Madiha; Jacobson, Caron A.; Kamdar, Manali K.; Karmali, Reem; Maddocks, Kami J.; Matasar, Matthew; Merryman, Reid W.; Munoz, Javier; Riedell, Peter A.; Ryan, Christine E.; Salles, Gilles; Sauter, Craig S.; Sawalha, Yazeed; Shouval, Roni; Shukla, Navika; Stanisic, Alexander, V; Therwhanger, Dylan; Van Besien, Herman; Wang, Yucai; Yamshon, Samuel; Zelenetz, Andrew D.; Palomba, Maria Lia; Jain, Preetesh; Kumar, Anita
Tumor Determinants of Response to CAR-T Therapy in Relapsed or Refractory Mantle Cell Lymphoma

弥漫大B细胞淋巴瘤复发或难治性情况下对CAR-T疗法的肿瘤决定因素

BLOOD
IF23.1
2024-11-050
PRE
Epstein-Peterson, Zachary D.; Ryan, Christine E.; Devlin, Sean M.; Accav, Noa Golan; Avigdor, Abraham; Corona, Magdalena; Danylesko, Ivetta; Dela Cruz, Jamie; Goy, Andre; Jacobson, Caron A.; Katz, Ofrat Beyar; Khatib, Hazim; Kumar, Anita; Leslie, Lori A.; Luna, Alejandro; Marcus, Ronit; Merryman, Reid W.; Perales, Miguel Angel; Rivas-Delgado, Alfredo; Salles, Gilles; Scordo, Michael; Sdayoor, Inbal; Shah, Gunjan L.; Shem-Tov, Noga; Shimoni, Avichai; Vahaba, Nataly; Yerushalmi, Ronit; Zelenetz, Andrew D.; Palomba, Maria Lia; Ip, Andrew; Shouval, Roni

研究方向

暂未获取到该数据
P
Philippe Armand
H 指数:88论文数:627被引数:3.6万
C
Caron A. Jacobson
H 指数:59论文数:580被引数:2.3万
J
Jennifer L. Crombie
H 指数:23论文数:169被引数:2,093
A
Ann S. LaCasce
H 指数:66论文数:388被引数:1.8万
R
Robert Redd
H 指数:39论文数:347被引数:9,678
D
David C. Fisher
H 指数:60论文数:350被引数:1.2万
A
Austin I. Kim
H 指数:15论文数:51被引数:968
E
Eric D. Jacobsen
H 指数:54论文数:359被引数:1.8万
O
Oreofe O. Odejide
H 指数:24论文数:139被引数:2,752
M
Matthew S. Davids
H 指数:60论文数:657被引数:1.8万